PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2019

CD51 distinguishes a subpopulation of bone marrow mesenchymal stem cells with distinct migratory potential: a novel cell-based strategy to treat acute myocardial infarction in mice.

Mouse / Ischaemia-reperfusion

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 31747966 ↗2019Reported benefit

CD51 distinguishes a subpopulation of bone marrow mesenchymal stem cells with distinct migratory potential: a novel cell-based strategy to treat acute myocardial infarction in mice.

MouseIschaemia-reperfusionCardiacC57BL/6J recipients; bone marrow donor cells from 14-day-old C57BL/6 miceMalen = 60 male C57BL/6J mice purchased for the study; two mice die…Intravenous, tail vein injection of cells suspended in 500 microlitres of saline30 min after myocardial infarction per the Methods; the abstract states immedia…

Model: Acute myocardial infarction produced by permanent ligation of the left anterior descending coronary artery approximately 0.3 cm from its origin, with a sham-operated comparison group

CD51-positive cells outperformed CD51-negative cells after intravenous delivery. Left ventricular ejection fraction was 53.2 plus or minus 5.4% versus 28.9 plus or minus 4.1% and fractional shortening 26.6 plus or minus 3.5% versus 13.5 plus or minus 2.0%. Infarct area as a proportion of left ventr…

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.8. Machine-extracted fields require source verification.